Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including Ribavirin

Clin Infect Dis. 2016 Feb 15;62(4):527-8. doi: 10.1093/cid/civ902. Epub 2015 Oct 27.

Authors

Marco Merli¹, Emanuela Messina¹, Stefania Salpietro², Adriano Lazzarin¹, Caterina Uberti-Foppa², Hamid Hasson²

Affiliations

¹ Infectious Diseases Clinic, San Raffaele Hospital Vita-Salute San Raffaele University, Milano, Italy.
² Infectious Diseases Clinic, San Raffaele Hospital.

PMID: 26508514
DOI: 10.1093/cid/civ902

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents / administration & dosage*
Antiviral Agents / adverse effects*
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / immunology*
Humans
Lymphopenia / chemically induced*
Ribavirin / administration & dosage*
Ribavirin / adverse effects*

Substances

Antiviral Agents
Ribavirin